Many with stiff-person syndrome also have other autoimmune

Credibility

Interest

Share:2 min read

Key Takeaway

About half of people with stiff-person syndrome have another autoimmune disease, especially diabetes or thyroid problems, which suggests doctors should check for these conditions.

What They Found

Stiff-person syndrome spectrum disorder (SPSD) often occurs with other autoimmune diseases: about 51% of people had at least one additional autoimmune condition. The most common were diabetes (including type 1 and a slow form called LADA) and autoimmune thyroid disease, which can cause too little or too much thyroid hormone. Less common but still seen were conditions like pernicious anemia (low vitamin B12 from immune attack), myasthenia gravis (a disease that causes muscle weakness), and celiac disease (an immune reaction to gluten). Some SPSD types had more additional autoimmune disease: PERM had the most (about 80%), classic SPS was next (about 62%), and focal/segmental SPS had fewer (about 38%). People who tested positive for GAD65 antibodies (an immune marker) were about twice as likely to have another autoimmune disease as those who were negative (64% vs 34%).

Who Should Care and Why

People with SPSD and their caregivers should care because finding another autoimmune disease early can change treatment and make daily life easier, like treating thyroid problems to reduce fatigue. Doctors and nurses should be aware that screening for diabetes and thyroid disease is often useful, similar to checking the oil and tires on a car when you know the engine has a problem. Patients with the PERM subtype or who are GAD65-positive should pay extra attention, since they have higher chances of other autoimmune issues. Caregivers can use this information to ask their care team about simple blood tests or referrals to specialists to catch problems early. This can lead to better symptom control and fewer surprises, for example treating low B12 to help thinking and energy or managing blood sugar to prevent complications.

Important Considerations

The study combined data from many smaller reports, which can mix different patient groups and testing methods, so numbers are estimates not exact counts. Most sources were observational (watching patients) rather than tests that prove cause, so we can't say one disease causes another—only that they often occur together. Also, the findings may not apply exactly to every clinic or country, so discuss screening plans with your own doctor before making changes.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Specific Symptoms Early Research MS Diagnostics

Article Topics:

Autoimmune diseasesMeta-analysisStiff-person syndrome

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News